National Institute of Health, Islamabad, Pakistan.
Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
PLoS One. 2021 Mar 23;16(3):e0248371. doi: 10.1371/journal.pone.0248371. eCollection 2021.
Since its emergence in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide including Pakistan. During the pandemic, whole genome sequencing has played an important role in understanding the evolution and genomic diversity of SARS-CoV-2. Although an unprecedented number of SARS-CoV-2 full genomes have been submitted in GISAID and NCBI, data from Pakistan is scarce. We report the sequencing, genomic characterization, and phylogenetic analysis of five SARS-CoV-2 strains isolated from patients in Pakistan. The oropharyngeal swabs of patients that were confirmed positive for SARS-CoV-2 through real-time RT-PCR at National Institute of Health, Pakistan, were selected for whole-genome sequencing. Sequencing was performed using NEBNext Ultra II Directional RNA Library Prep kit for Illumina (NEW ENGLAND BioLabs Inc., MA, US) and Illumina iSeq 100 instrument (Illumina, San Diego, US). Based on whole-genome analysis, three Pakistani SARS-CoV-2 strains clustered into the 20A (GH) clade along with the strains from Oman, Slovakia, United States, and Pakistani strain EPI_ISL_513925. The two 19B (S)-clade strains were closely related to viruses from India and Oman. Overall, twenty-nine amino acid mutations were detected in the current study genome sequences, including fifteen missense and four novel mutations. Notably, we have found a D614G (aspartic acid to glycine) mutation in spike protein of the sequences from the GH clade. The G614 variant carrying the characteristic D614G mutation has been shown to be more infectious that lead to its rapid spread worldwide. This report highlights the detection of GH and S clade strains and G614 variant from Pakistan warranting large-scale whole-genome sequencing of strains prevalent in different regions to understand virus evolution and to explore their genetic diversity.
自在中国出现以来,严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)已在包括巴基斯坦在内的全球范围内传播。在大流行期间,全基因组测序在了解 SARS-CoV-2 的进化和基因组多样性方面发挥了重要作用。尽管在 GISAID 和 NCBI 中提交了前所未有的 SARS-CoV-2 全基因组序列,但来自巴基斯坦的数据却很少。我们报告了从巴基斯坦患者中分离出的五株 SARS-CoV-2 株的测序、基因组特征和系统发育分析。从巴基斯坦国家卫生研究院通过实时 RT-PCR 确诊为 SARS-CoV-2 阳性的患者的咽拭子被选择用于全基因组测序。使用来自新英格兰生物实验室公司(美国马萨诸塞州)的 NEBNext Ultra II 定向 RNA 文库制备试剂盒 for Illumina 和 Illumina iSeq 100 仪器(Illumina,美国圣地亚哥)进行测序。基于全基因组分析,三种巴基斯坦 SARS-CoV-2 株与来自阿曼、斯洛伐克、美国和巴基斯坦株 EPI_ISL_513925 的 20A(GH)进化枝聚集在一起。两种 19B(S)-clade 株与来自印度和阿曼的病毒密切相关。总的来说,在本研究的基因组序列中检测到二十九个氨基酸突变,包括十五个错义突变和四个新突变。值得注意的是,我们在 GH 进化枝序列的刺突蛋白中发现了 D614G(天冬氨酸到甘氨酸)突变。携带特征性 D614G 突变的 G614 变体已被证明更具传染性,导致其在全球范围内迅速传播。本报告强调了在巴基斯坦检测到 GH 和 S 进化枝株和 G614 变体,需要对不同地区流行的株进行大规模全基因组测序,以了解病毒进化并探索其遗传多样性。